Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Capitalization 365B 52.96B 46.29B 41.82B 40.01B 72.77B 4,899B 75.64B 500B 198B 2,340B 199B 195B 8,453B P/E ratio 2025 *
42.4x
P/E ratio 2026 * 37.6x
Enterprise value 327B 47.38B 41.42B 37.42B 35.8B 65.11B 4,383B 67.68B 447B 177B 2,094B 178B 174B 7,562B EV / Sales 2025 *
9.98x
EV / Sales 2026 * 8.75x
Free-Float
52.38%
Yield 2025 *
0.48%
Yield 2026 * 0.55%
1 day-0.34%
1 week-0.81%
Current month-2.56%
1 month-5.36%
3 months-10.22%
6 months-20.25%
Current year-7.49%
1 week 54.95
Extreme 54.95
56.75
1 month 52.67
Extreme 52.67
58.48
Current year 52.67
Extreme 52.67
65.83
1 year 44.2
Extreme 44.2
74.04
3 years 35.51
Extreme 35.51
74.04
5 years 27
Extreme 27
79.03
10 years 13.72
Extreme 13.7195
97.39
Manager TitleAgeSince
Director of Finance/CFO 49 18/11/2021
President - 01/04/2025
Compliance Officer 34 31/05/2021
Director TitleAgeSince
Director/Board Member 56 15/01/2020
Director/Board Member 50 15/01/2020
Chairman 67 07/07/2021
Change 5d. change 1-year change 3-years change Capi.($)
-0.34%-0.81%+18.41%+33.18% 52.96B
+0.80%-0.53%+21.09%+198.99% 880B
-0.21%+0.47%+48.34%+56.48% 582B
-2.52%-4.53%+3.74%+42.59% 388B
-0.20%-3.73%+2.86%+22.46% 324B
-0.62%-0.87%+20.26%+32.58% 295B
-0.44%-3.38%+22.78%+57.24% 293B
-0.26%-0.16%+22.25%+7.41% 286B
-0.43%-0.90%+16.74%+55.90% 197B
-0.15%+0.74%+30.11%+82.03% 180B
Average -0.42%-1.30%+20.66%+58.89% 347.91B
Weighted average by Cap. -0.27%-1.34%+22.36%+82.74%

Financials

2025 *2026 *
Net sales 32.73B 4.75B 4.15B 3.75B 3.59B 6.52B 439B 6.78B 44.78B 17.74B 210B 17.81B 17.43B 758B 36.59B 5.31B 4.64B 4.19B 4.01B 7.29B 491B 7.58B 50.06B 19.84B 234B 19.91B 19.49B 847B
Net income 7.99B 1.16B 1.01B 915M 876M 1.59B 107B 1.66B 10.93B 4.33B 51.22B 4.35B 4.26B 185B 10.21B 1.48B 1.29B 1.17B 1.12B 2.03B 137B 2.11B 13.96B 5.53B 65.39B 5.55B 5.44B 236B
Net Debt -38.47B -5.58B -4.88B -4.4B -4.21B -7.66B -516B -7.97B -52.62B -20.85B -246B -20.93B -20.49B -890B -45.09B -6.54B -5.72B -5.16B -4.94B -8.98B -605B -9.34B -61.68B -24.45B -289B -24.54B -24.02B -1,044B
Logo Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products: - anti-tumor drugs (No. 1 Chinese); - Anesthetic drugs; - contrast agents: used in medical imaging; - anti-inflammatory drugs; - drugs for the treatment of cardiovascular diseases.
Employees
20,238
Date Price Change Volume
13/03/26 55.11 ¥ -0.34% 24,416,440
12/03/26 55.30 ¥ -0.95% 26,669,130
11/03/26 55.83 ¥ -1.27% 32,125,920
10/03/26 56.55 ¥ +2.93% 47,360,490
09/03/26 54.94 ¥ -1.12% 42,623,320
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
55.11CNY
Average target price
82.39CNY
Spread / Average Target
+49.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600276 Stock
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW